Literature DB >> 34142211

Magnetic resonance imaging and Ménière's disease-unavoidable alliance.

Rita Sousa1, Francisco Raposo2, Carla Guerreiro2, David Berhanu2, Tiago Eça3, J Campos4, Leonel Luís3,5.   

Abstract

Ménière's disease (MD) is a clinical syndrome characterized by recurrent episodes of spontaneous vertigo, unilateral fluctuating sensorineural hearing loss, tinnitus, and aural fullness. Endolymphatic hydrops is recognized as the pathophysiological substrate of the disease, having been demonstrated in anatomical pathological studies and more recently by magnetic resonance imaging (MRI). The current criteria of the disease, however, remain symptom based and do not include the demonstration of endolymphatic hydrops. The authors review MRI techniques and diagnostic criteria of endolymphatic hydrops and the role of MRI in MD is discussed.

Entities:  

Keywords:  Endolymphatic hydrops; Hydropic Ear; Imaging inner ear; Magnetic resonance imaging; Menière´s disease

Year:  2021        PMID: 34142211     DOI: 10.1007/s00234-021-02744-5

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  48 in total

1.  Endolymphatic hydrops in Ménière's disease: cause, consequence, or epiphenomenon?

Authors:  Carol A Foster; Robert E Breeze
Journal:  Otol Neurotol       Date:  2013-09       Impact factor: 2.311

2.  Visualization of endolymphatic hydrops in patients with Meniere's disease.

Authors:  Tsutomu Nakashima; Shinji Naganawa; Makoto Sugiura; Masaaki Teranishi; Michihiko Sone; Hideo Hayashi; Seiichi Nakata; Naomi Katayama; Ieda Maria Ishida
Journal:  Laryngoscope       Date:  2007-03       Impact factor: 3.325

3.  Committee on Hearing and Equilibrium guidelines for reporting treatment results in Meniere's disease.

Authors:  B W Pearson; D E Brackmann
Journal:  Otolaryngol Head Neck Surg       Date:  1985-10       Impact factor: 3.497

4.  Prevalence of Menière's disease in general population of Southern Finland.

Authors:  Mari Havia; Erna Kentala; Ilmari Pyykkö
Journal:  Otolaryngol Head Neck Surg       Date:  2005-11       Impact factor: 3.497

5.  An attempt to classify the primary vertigos.

Authors:  R Hinchcliffe
Journal:  J Laryngol Otol       Date:  1967-08       Impact factor: 1.469

Review 6.  On the classification of hydropic ear disease (Menière's disease).

Authors:  R Gürkov; J Hornibrook
Journal:  HNO       Date:  2018-06       Impact factor: 1.284

Review 7.  Meniere's disease.

Authors:  Tsutomu Nakashima; Ilmari Pyykkö; Megan A Arroll; Margaretha L Casselbrant; Carol A Foster; Nauman F Manzoor; Cliff A Megerian; Shinji Naganawa; Yi-Ho Young
Journal:  Nat Rev Dis Primers       Date:  2016-05-12       Impact factor: 52.329

8.  Diagnostic criteria for Menière's disease.

Authors:  Jose A Lopez-Escamez; John Carey; Won-Ho Chung; Joel A Goebel; Måns Magnusson; Marco Mandalà; David E Newman-Toker; Michael Strupp; Mamoru Suzuki; Franco Trabalzini; Alexandre Bisdorff
Journal:  J Vestib Res       Date:  2015       Impact factor: 2.435

Review 9.  Endolymphatic hydrops: pathophysiology and experimental models.

Authors:  Alec N Salt; Stefan K Plontke
Journal:  Otolaryngol Clin North Am       Date:  2010-10       Impact factor: 3.346

Review 10.  What is Menière's disease? A contemporary re-evaluation of endolymphatic hydrops.

Authors:  R Gürkov; I Pyykö; J Zou; E Kentala
Journal:  J Neurol       Date:  2016-04-15       Impact factor: 4.849

View more
  2 in total

1.  Endolymphatic hydrops in the unaffected ear of patients with unilateral Ménière's disease.

Authors:  Carlos Guajardo-Vergara; Victor Suárez-Vega; Pablo Dominguez; Raquel Manrique-Huarte; Lorea Arbizu; Nicolás Pérez-Fernández
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-05-16       Impact factor: 3.236

2.  Comparison between 3D SPACE FLAIR and 3D TSE FLAIR in Menière's disease.

Authors:  Anja Bernaerts; Nick Janssen; Floris L Wuyts; Cathérine Blaivie; Robby Vanspauwen; Joost van Dinther; Andrzej Zarowski; Erwin Offeciers; Filip Deckers; Jan W Casselman; Bert De Foer
Journal:  Neuroradiology       Date:  2022-02-12       Impact factor: 2.804

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.